Virion Biotherapeutics (formerly known as Virion Health) is a biotechnology company focused on novel therapeutics for respiratory viral infections (RVIs). It develops proprietary Therapeutic Interfering Particles (TIPs) to transform the clinical management of human RVIs. The Company's biologicals enhance a naturally-occurring dual mechanism that interferes with viral replication, preventing infection and stopping the disease.
Type | Private | |
Founded | 2017 | |
HQ | London, GB | Map |
Website | virionbiotx.com |
Employees (est.) (Jan 2021) | 2 | |
Cybersecurity rating | A | More |
Founding Date | 2017 |
Virion Biotherapeutics total Funding | $17.1 m |
Virion Biotherapeutics latest funding size | $17.12 m |
Time since last funding | 3 years ago |
Virion Biotherapeutics investors | Abingworth |
Cash (31-Mar-2018) | 7.2m |
GBP | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|
Cash | 1.0k | 7.2m | |
Current Assets | 1.0k | 1.0k | 7.3m |
FY, 2016 | |
---|---|
Financial Leverage | 1 x |
Virion Biotherapeutics has 149 Twitter Followers. The number of followers has decreased 0.3% month over month and increased 0.9% quarter over quarter
When was Virion Biotherapeutics founded?
Virion Biotherapeutics was founded in 2017.
How many employees does Virion Biotherapeutics have?
Virion Biotherapeutics has 2 employees.
Who are Virion Biotherapeutics competitors?
Competitors of Virion Biotherapeutics include LifebankUSA, PreciThera and Brainstorm Cell Therapeutics.
Where is Virion Biotherapeutics headquarters?
Virion Biotherapeutics headquarters is located at 38 Jermyn St, St. James's, London.
Where are Virion Biotherapeutics offices?
Virion Biotherapeutics has offices in London and West Midlands.
How many offices does Virion Biotherapeutics have?
Virion Biotherapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies